These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1764162

  • 21. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
    Aubel-Sadron G, Londos-Gagliardi D.
    Biochimie; 1984 May; 66(5):333-52. PubMed ID: 6380596
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
    Babudri N, Pani B, Tamaro M, Monti-Bragadin C, Zunino F.
    Br J Cancer; 1984 Jul; 50(1):91-6. PubMed ID: 6378238
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics.
    Studzian K, Wasowska M, Piestrzeniewicz MK, Wilmańska D, Szmigiero L, Oszczapowicz I, Gniazdowski M.
    Neoplasma; 2001 Jul; 48(5):412-8. PubMed ID: 11845988
    [Abstract] [Full Text] [Related]

  • 25. Biological properties of new derivatives of daunorubicin.
    Wasowska-Lukawska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicz I.
    In Vivo; 2007 Jul; 21(2):413-6. PubMed ID: 17436596
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
    Kanter PM, Schwartz HS.
    Cancer Res; 1979 Sep; 39(9):3661-72. PubMed ID: 476691
    [Abstract] [Full Text] [Related]

  • 29. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.
    Schlage P, Mezo G, Orbán E, Bosze S, Manea M.
    J Control Release; 2011 Dec 10; 156(2):170-8. PubMed ID: 21864594
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues.
    Fan E, Shi W, Lowary TL.
    J Org Chem; 2007 Apr 13; 72(8):2917-28. PubMed ID: 17373847
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S, Estrov Z, Kantarjian HM, Harris D, Van Q, Fokt I, Przewloka T, Godlewski C, Woynarowski JM, Priebe W.
    Anticancer Res; 2001 Apr 13; 21(6A):3777-84. PubMed ID: 11911247
    [Abstract] [Full Text] [Related]

  • 39. Cellular pharmacology of idarubicinol in multidrug-resistant LoVo cell lines.
    Toffoli G, Corona G, Simone F, Gigante M, De Angeli S, Boiocchi M.
    Int J Cancer; 1996 Jul 03; 67(1):129-37. PubMed ID: 8690513
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.